Search

Your search keyword '"Weger R"' showing total 255 results

Search Constraints

Start Over You searched for: Author "Weger R" Remove constraint Author: "Weger R" Search Limiters Full Text Remove constraint Search Limiters: Full Text
255 results on '"Weger R"'

Search Results

1. Multi-omics integration identifies key upstream regulators of pathomechanisms in hypertrophic cardiomyopathy due to truncating MYBPC3 mutations

6. Multi-omics integration identifies key upstream regulators of pathomechanisms in hypertrophic cardiomyopathy due to truncating MYBPC3 mutations

7. Multi-omics integration identifies key upstream regulators of pathomechanisms in hypertrophic cardiomyopathy due to truncating MYBPC3 mutations

8. Multi-omics integration identifies key upstream regulators of pathomechanisms in hypertrophic cardiomyopathy due to truncating MYBPC3 mutations

9. The EuroChimerism concept for a standardized approach to chimerism analysis after allogeneic stem cell transplantation

12. H3K27ac acetylome signatures reveal the epigenomic reorganization in remodeled non-failing human hearts

13. Plasma Immunoglobulin Levels Prior to Cardiac Transplantation are Associated with Post-Transplantation Survival

16. Health-related quality of life in multiple myeloma and mapping algorithms to derive health-state utility values: an overview

18. Effectiveness of treatment sequences for elderly patients with multiple myeloma - a comparison of treatment schedules from clinical trials and experience from the Austrian Myeloma Registry

19. Clinical versus histological grading in the assessment of cutaneous graft versus host disease

21. Mapping Health-Related Quality of Life in Multiple Myeloma: Assessment of Existing Mapping Algorithms

22. PCN163 SEQUENTIAL TREATMENT REGIMENS FOR ELDERLY PATIENTS WITH MULTIPLE MYELOMA: A COST-EFFECTIVENESS ANALYSIS INCLUDING EXPERIENCE FROM REAL-WORLD DATA

28. Imatinib treatment of poor prognosis mesenchymal-type primary colon cancer : A proof-of-concept study in the preoperative window period (ImPACCT)

31. Changes in Myocardial Microvascularisation After Heart Transplantation and During Cardiac Allograft Vasculopathy

32. In Vivo Anti-MicroRNA Treatment in a Humanized Mouse Model for Allograft Vasculopathy

33. Liquid Biopsies: Non-Invasive Rejection Detection After Heart Transplantation

34. Imatinib treatment of poor prognosis mesenchymal-type primary colon cancer: A proof-of-concept study in the preoperative window period (ImPACCT)

35. Donor-Specific Antibodies Are Produced Locally in Ectopic Lymphoid Structures in Cardiac Allografts

37. Imatinib treatment of poor prognosis mesenchymal-type primary colon cancer: a proof-of-concept study in the preoperative window period (ImPACCT)

38. GABA-B Agonist Baclofen Normalizes Auditory-Evoked Neural Oscillations and Behavioral Deficits in theFmr1Knockout Mouse Model of Fragile X Syndrome

39. Comparison of intramedullary myeloma and corresponding extramedullary soft tissue plasmacytomas using genetic mutational panel analyses

40. Identification of human ccn2 [*] (connective tissue growth factor) promoter polymorphisms

45. Both Recipient and Donor Cells Are Involved in Human Cardiac Allograft Vasculopathy

46. Cytokine and MicroRNA Profiles of Ectopic Lymphoid Structures in Cardiac Allograft Vasculopathy

47. The Amount of Autophagy-Related Cardiomyocyte Cell Death Is Associated With the Type of Pathogenic Mutation in Genetic Dilated Cardiomyopathy

Catalog

Books, media, physical & digital resources